Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - May 2013

The 6th (2013) International Bio-pharmaceutical R&D Innovation Asia Summit

27 May 2013 - 29 May 2013 - Shanghai, China

Bookmark and Share

The 6th International Bio-pharmaceutical Industrial Development Innovation Forum & The 6th (2013) International Bio-pharmaceutical R&D Innovation Asia Summit will be held on May.27th-29th, 2012 in Shanghai, which organized by SEBMC, supported by International Alliance of Innovation Drug Research and European Association for Bio-industries and Biotechnology Industry Organization, at that time, more than 400 multinational pharmaceutical company leaders, global top level drug & medicine scientist and experts who from USA, Europe, China and Asia will join in this Forum, it will concern Bio-pharmaceutical, new drug research, innovative drug R&D outsourcing, pharmaceutical clinical research, translational medicine and personalized treatment technology, the Forum focus on new anticancer drugs, cardiovascular drugs, anti-diabetic drugs, neurodegenerative drugs, anti-infective drugs and resistance to major diseases drug innovation and clinical applications, antibody humanized technology and pharmaceutical technology invention, tumor molecular targeted drug development and targeted therapy technology, monoclonal antibody drug development and cell line development technology, Clinical Oncology Translational Medicine and individualized treatment, the forum will also explore that the Asian Pharmaceutical face the challenges of global blockbuster stage bio-pharmaceutical patents expiring peak, how to search for the production line of potential new drug development in Asia, how to control control the the new drug R&D investment and seek a reasonable balance during Drug Listing! Bring new drug development to maximize profits, to accelerate the transformation of drug R&D from the laboratory to clinical application, to search for future Asian new drug R&D trend and innovative model of win-win cooperation, to inject change drivers positive energy for the fast-growing Asian and emerging market R & D, to decode the Asian innovative drugs and translational medicine revolution, promote Asian new drug development and clinical medicine innovation. At the same time, The 6th (2013) International Bio-pharmaceutical and Biochemistry Instrument (Shanghai) Exhibition will be also held together, This exhibition will display comprehensively the Asian and international cutting-edge biomedical technology, the innovative biological products, laboratory equipment, clinical treatment and diagnostic testing equipment, diagnostic reagents and biochemical analysis equipment and other innovative products, this forum will be the most forefront event in Asian Pharmaceutical .

Further information
Scientific News
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos